Edward (alex) Estrada
Vice President
Research & Development
Amaranth Medical
Singapore
Biography
Mr. Estrada is vice president of research and development for Amaranth Medical, Inc., and has more than 30 years of experience working with medical devices. Before joining the company, he was vice president, research and development, at NovoStent Corporation, a medical device start-up company developing a novel Nitinol stent for the superficial femoral artery (SFA). Previously, Mr. Estrada spent 19 years within the Advanced Cardiovascular Systems/Guidant/Abbott Vascular organizations, most recently as director of research and development for the endovascular division of Abbott. He has been instrumental in developing a drug eluting stent for the SFA as well as the first carotid stent to receive FDA approval. Mr. Estrada has been an inventor on numerous patents and patent applications. He holds a BS in mechanical engineering from California Polytechnic State University at San Luis Obispo.
Research Interest
Research & Development